Functional determination of soluble fibrin polymers (SFP) in plasma

Thrombosis and Haemostasis

Volumn 84, Issue 6, 2000, Pages 1120-1121

  Stief, T W ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FIBRIN; FIBRIN MONOMER; PLASMIN INHIBITOR; TRITON X 100;

FIBRIN POLYMERIZATION; HEMOSTASIS; HUMAN; LETTER; MULTIPLE ORGAN FAILURE; NONHUMAN; PLASMA; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; SOLUBILIZATION;

EID: 0034530477     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614182     Document Type: Letter

References (10)

1. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy
2. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay
3. Soluble fibrin: A predictor for the development and outcome of multiple organ failure
4. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction
5. Thrombus Precursor Protein and the measurement of thrombosis in patients with acute chest pain syndrome
6. Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications
7. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation
8. The blood fibrinolysis/deep-sea analogy: A hypothesis on singlet oxygen/photons as natural antithrombotics
9. A simple method for producing degradation products of fibrinogen by an insoluble derivative of plasmin
10. Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction